Kraig Biocraft Labs
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce sp… Read more
Kraig Biocraft Labs (KBLB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.058x
Based on the latest financial reports, Kraig Biocraft Labs (KBLB) has a cash flow conversion efficiency ratio of 0.058x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-461.86K) by net assets ($-7.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kraig Biocraft Labs - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Kraig Biocraft Labs's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kraig Biocraft Labs Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kraig Biocraft Labs ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lakeland Industries Inc
NASDAQ:LAKE
|
-0.023x |
|
SBC Exports Limited
NSE:SBC
|
0.009x |
|
DEE Development Eng Ltd
NSE:DEEDEV
|
1.146x |
|
Molecular Partners AG
PINK:MLLCF
|
-0.099x |
|
Shanghai Jinjiang International Travel Co Ltd
SHG:900929
|
-0.018x |
|
Simpac
KO:009160
|
0.039x |
|
HANSARD GLOBAL PLC LS-50
F:H9G
|
N/A |
|
Doosan Solus Co Ltd Pref 1P
KO:33637K
|
0.006x |
Annual Cash Flow Conversion Efficiency for Kraig Biocraft Labs (2014–2024)
The table below shows the annual cash flow conversion efficiency of Kraig Biocraft Labs from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-8.15 Million | $-1.84 Million | 0.226x | +3.49% |
| 2023-12-31 | $-5.71 Million | $-1.24 Million | 0.218x | -59.31% |
| 2022-12-31 | $-3.52 Million | $-1.89 Million | 0.536x | +57.58% |
| 2021-12-31 | $-5.30 Million | $-1.80 Million | 0.340x | +78.15% |
| 2020-12-31 | $-6.57 Million | $-1.25 Million | 0.191x | -5.46% |
| 2019-12-31 | $-5.39 Million | $-1.09 Million | 0.202x | +283.12% |
| 2018-12-31 | $-4.46 Million | $-235.00K | 0.053x | -75.61% |
| 2017-12-31 | $-3.38 Million | $-729.54K | 0.216x | -49.58% |
| 2016-12-31 | $-2.36 Million | $-1.01 Million | 0.429x | -15.97% |
| 2015-12-31 | $-1.90 Million | $-967.56K | 0.510x | -30.87% |
| 2014-12-31 | $-1.23 Million | $-904.56K | 0.738x | -- |